In addition, because of the novelty of EVALI, the potential pulmonary morbidity seen with ACRCC-Δ 8 -THC products substances may be significant, and clinically is oftentimes untested, overlooked, and goes undiagnosed; therefore, the true breadth of the EVALI epidemic remains unknown.
← all excerpts
The Dark Side of Cannabidiol: The Unanticipated Social and Clinical Implications of Synthetic Δ<sup>8</sup>-THC.
1
—
—